Form 6-K
TEVA PHARMACEUTICAL INDUSTRIES LTD filed this Form 6-K on 05/11/2017
Document Outline
Entire Document (6474.1 KB)
Subdocument 1 - 6-K - FORM 6-K
Page 1 - UNITED STATES
Page 2 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 3 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 4 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 5 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 6 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 7 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 8 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 9 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 10 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 11 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 12 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 13 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 14 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 15 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 16 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 17 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 18 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 19 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 20 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 21 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 22 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 23 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 24 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 25 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 26 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 27 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 28 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 29 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 30 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 31 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 32 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 33 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 34 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 35 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 36 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 37 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 38 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 39 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 40 - OPERATING AND FINANCIAL REVIEW AND PROSPECTS
Page 41 - Introduction
Page 42 - Changes in Senior Management
Page 43 - Segment Information
Page 44 - United States Generic Medicines Revenues
Page 45 - Europe Generic Medicines Revenues
Page 46 - ROW Generic Medicines Revenues
Page 47 - Generic Medicines Gross Profit
Page 48 - Specialty Medicines Revenues
Page 49 - Central Nervous System
Page 50 - Nuvigil
Page 51 - Women s Health
Page 52 - Other Activities
Page 53 - General and Administrative (G A) Expenses
Page 54 - Financial Expenses, Net
Page 55 - Diluted Shares Outstanding and Earnings Per Share
Page 56 - 2017 Debt Balance and Movements
Page 57 - Shareholders Equity
Page 58 - Supplemental Non-GAAP Income Data
Page 59 - N/A
Page 60 - N/A
Page 61 - Non-GAAP Tax Rate
Page 62 - SIGNATURES
Subdocument 2 - EX-2.1 - EX-2.1
Page 1 - Exhibit 2.1
Page 2 - TABLE OF CONTENTS
Page 3 - N/A
Page 4 - N/A
Page 5 - CREDIT AGREEMENT
Page 6 - Anti-Money Laundering Laws
Page 7 - Basel Committee
Page 8 - Code
Page 9 - Disruption Event
Page 10 - extraordinary
Page 11 - Subject Transaction
Page 12 - (a)
Page 13 - Section
Page 14 - GAAP
Page 15 - provided
Page 16 - Interest Receivable
Page 17 - Lender Party
Page 18 - Maturity Date
Page 19 - Organized Crime Group Quasi-Member
Page 20 - Quotation Day
Page 21 - SEC
Page 22 - Standard Securitization Undertakings
Page 23 - Total Consolidated Debt
Page 24 - Tranche A Maturity Extension Date
Page 25 - Yen LIBO Rate Screen Rate
Page 26 - hozen kanrinin
Page 27 - provided
Page 28 - Exhibit F
Page 29 - Termination and Reduction of Commitments; Term Loans
Page 30 - paragraph
Page 31 - Section
Page 32 - provided
Page 33 - Reference Bank Rate
Page 34 - provided
Page 35 - Illegality
Page 36 - Unpaid Sum
Page 37 - Treatment of Certain Refunds
Page 38 - Payments Generally; Pro Rata Treatment; Sharing of Set
Page 39 - Section
Page 40 - Section
Page 41 - fifth
Page 42 - Approvals; No Conflicts
Page 43 - Litigation
Page 44 - ERISA
Page 45 - Taxes
Page 46 - paragraphs (a)
Page 47 - ARTICLE IV
Page 48 - Section
Page 49 - KK Fiscal Year
Page 50 - provided
Page 51 - Payment of Taxes
Page 52 - ARTICLE VI
Page 53 - Section
Page 54 - Permitted Encumbrances
Page 55 - provided
Page 56 - provided
Page 57 - ARTICLE VII
Page 58 - clause
Page 59 - tegata-koukanjo
Page 60 - ARTICLE VIII
Page 61 - Duties of Administrative Agent; Exculpatory Provisions
Page 62 - Article
Page 63 - Delegation of Duties
Page 64 - Section
Page 65 - [Reserved]
Page 66 - Guaranty Absolute
Page 67 - Waivers and Acknowledgments
Page 68 - Subordinated Obligations
Page 69 - Agent Authorization.
Page 70 - clause
Page 71 - Expenses; Indemnity; Damage Waiver
Page 72 - (EXCLUDING ANY SUCH CLAIM, DAMAGE, LOSS, LIABILITY, COST, PENALTY, FEE OR EXPENSE SOUGHT TO BE RECOV
Page 73 - Successors and Assigns
Page 74 - Required Consents
Page 75 - Participant
Page 76 - Sections
Page 77 - Governing Law; Jurisdiction; Consent to Service of Process
Page 78 - Section
Page 79 - Sections
Page 80 - Section
Page 81 - Section
Page 82 - USA Patriot Act Notice;
Page 83 - N/A
Page 84 - kousei shosho
Page 85 - clause (a)
Page 86 - (a)
Page 87 - N/A
Page 88 - N/A
Page 89 - N/A
Page 90 - N/A
Page 91 - N/A
Page 92 - SCHEDULE 1A
Page 93 - SCHEDULE 1B
Page 94 - SCHEDULE 2.01
Page 95 - SCHEDULE 3.18
Page 96 - SCHEDULE 6.03
Page 97 - EXHIBIT A
Page 98 - Assignment Date
Page 99 - N/A
Page 100 - Representations and Warranties
Page 101 - Payments
Page 102 - EXHIBIT B
Page 103 - EXHIBIT C
Page 104 - EXHIBIT D
Page 105 - EXHIBIT E
Page 106 - EXHIBIT F
Page 107 - Annex A
Page 108 - Confidentiality of Reference Bank Quotations
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (What's this?)
XBRL Viewer